Table 1 SALL4 expression and clinicopathological features in 26 choriocarcinoma patients.
Clinical characteristic | Number of patients | SALL4 | P value | |
|---|---|---|---|---|
Low expression | High expression | |||
Age (year) | ||||
<35 | 10 | 5 | 5 | 0.756 |
≥35 | 16 | 7 | 9 | |
Risk scores | ||||
≤6 | 11 | 9 | 2 | 0.002 |
>6 | 15 | 3 | 12 | |
FIGO stages | ||||
I | 5 | 5 | 0 | <0.001 |
II | 8 | 6 | 2 | |
III–IV | 13 | 1 | 12 | |
Chemotherapy | ||||
No | 12 | 9 | 3 | 0.006 |
Yes | 14 | 3 | 11 | |